fungifex 250mg tablets
remedica ltd (0000003171) aharnon str., lemesos, 3056 - terbinafine hydrochloride - tablets - 250mg - terbinafine hydrochloride (8000001212) 281,25mg - terbinafine
lamisil 1% δερματικός ψεκασμός
glaxosmithkline ΚΑΤΑΝΑΛΩΤΙΚΑ ΠΡΟΙΟΝΤΑ ΥΓΕΙΑΣ ΕΛΛΑΣ ΜΟΝΟΠΡΟΣΩΠΗ ΑΝΩΝΥΜΗ ΕΤΑΙΡΕΙΑ (gsk ch ΕΛΛΑΣ ΜΟΝΟΠΡΟΣΩΠΗ Α.Ε.) (0000011419) 274 kifissias avenue, halandri, athens, 15232 - terbinafine hydrochloride - Δερματικός ψεκασμός - 1% - terbinafine hydrochloride (8000001212) 0,01g - terbinafine
lamisil 125mg tablets
novartis ireland limited (0000010772) vista building, elm park, merrion road, ballsbridge, dublin, dublin 4 - terbinafine hydrochloride - tablets - 125mg - terbinafine hydrochloride (8000001212) 140,625mg - terbinafine
lamisil 250mg tablets
novartis ireland limited (0000010772) vista building, elm park, merrion road, ballsbridge, dublin, dublin 4 - terbinafine hydrochloride - tablets - 250mg - terbinafine hydrochloride (8000001212) 281,25mg - terbinafine
lamisil 1% cream
haleon hellas single member societe anonyme (trading as haleon hellas) (0000012468) 274 kifissias avenue , chalandri, athens, 15232 - terbinafine hydrochloride - cream - 1% - terbinafine hydrochloride (8000001212) 10mg - terbinafine
medofloran 250mg tablets
medochemie ltd (0000003169) 1-10 constantinoupoleos str, lemesos, 3011, 51409 (3505) - terbinafine hydrochloride - tablets - 250mg - terbinafine hydrochloride (8000001212) 250mg - terbinafine
terbigram 1% κρεμα
lavipharm ae (0000000061) ΑΓ.ΜΑΡΙΝΑΣ, ΠΑΙΑΝΙΑ, 19002 - terbinafine hydrochloride - ΚΡΕΜΑ - 1% - 8000024513 terbinafine hydrochloride 10.000000 mg - terbinafine
termisil 1% w/w κρεμα
genepharm ae (0000000073) 18 ΧΛΜ. Λ. ΜΑΡΑΘΩΝΟΣ, ΠΑΛΛΗΝΗ ΑΤΤΙΚΗΣ, 15351 - terbinafine hydrochloride - ΚΡΕΜΑ - 1% w/w - 8000024513 terbinafine hydrochloride 10.000000 mg - terbinafine
termisil 250mg/tab δισκιο
genepharm ae (0000000073) 18 ΧΛΜ. Λ. ΜΑΡΑΘΩΝΟΣ, ΠΑΛΛΗΝΗ ΑΤΤΙΚΗΣ, 15351 - terbinafine hydrochloride - ΔΙΣΚΙΟ - 250mg/tab - 8000024513 terbinafine hydrochloride 281.250000 mg - terbinafine
tafinlar
novartis europharm limited - dabrafenib mesilate - Μελανώμα - Αντινεοπλασματικοί παράγοντες - melanomadabrafenib as monotherapy or in combination with trametinib is indicated for the treatment of adult patients with unresectable or metastatic melanoma with a braf v600 mutation (see sections 4. 4 και 5. Επικουρική θεραπεία melanomadabrafenib σε συνδυασμό με το trametinib ενδείκνυται για την επικουρική θεραπεία ενηλίκων ασθενών με μελάνωμα Σταδίου ΙΙΙ με braf v600 mutation, μετά την πλήρη εκτομή. non-small cell lung cancer (nsclc)dabrafenib in combination with trametinib is indicated for the treatment of adult patients with advanced non-small cell lung cancer with a braf v600 mutation.